← HHS Federal Register rules

Intramammary Dosage Forms; Ceftiofur

other · Food and Drug Administration · Rule · Published 2005-02-28 · Effective 2005-02-28 · 70 FR 9515

Document

Document number
05-3834
Federal Register citation
70 FR 9515
CFR reference
21 CFR 526
Type
Rule
Action
Final rule.
Category
other
Sub-agency
Food and Drug Administration
Publication date
2005-02-28
Effective date
2005-02-28

Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of a new animal drug application (NADA) filed by Pharmacia & Upjohn Co., a Division of Pfizer, Inc. The NADA provides for the veterinary prescription use of ceftiofur hydrochloride suspension, by intramammary infusion, for the treatment of clinical mastitis in lactating dairy cattle.

Source

Authoritative
Federal Register document
Machine
JSON-LD · Markdown